Skip to main content

Page of 2 next disabled
and
  1. No Access

    Article

    Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications

    International Classification of Diseases (ICD)-10 codes may correspond to cirrhosis diagnosis. However, these codes have not been as well studied as ICD-9 codes. We aimed to evaluate the positive predictive va...

    Daniel A. Burkholder, Isabel J. Moran in Digestive Diseases and Sciences (2022)

  2. Article

    Open Access

    Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice

    Excessive cholangiocyte expansion (ductular reaction) promotes liver disease progression, but the underlying mechanism is poorly understood. Here we identify biliary NF-κB-inducing kinase (NIK) as a pivotal re...

    Zhiguo Zhang, **ao Zhong, Hong Shen, Liang Sheng in Nature Communications (2022)

  3. No Access

    Article

    Accuracy of Non-invasive Indices for Diagnosing Hepatic Steatosis Compared to Imaging in a Real-World Cohort

    Nonalcoholic fatty liver disease is common and under-diagnosed. This study evaluated the accuracy of several previously reported indices, including hepatic steatosis index, alanine aminotransferase (ALT) metho...

    Jacob V. DiBattista, Daniel A. Burkholder, Anna S. Lok in Digestive Diseases and Sciences (2022)

  4. No Access

    Article

    Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis

    Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM) analyze hemostatic function in patients with coagulopathy. We sought to quantify the impact of TEG and ROTEM-guided transfusion algorithms on...

    Abhishek Shenoy, Jeremy Louissaint, Carol Shannon in Digestive Diseases and Sciences (2022)

  5. No Access

    Article

    The scientific basis of combination therapy for chronic hepatitis B functional cure

    Functional cure of chronic hepatitis B (CHB) — or hepatitis B surface antigen (HBsAg) loss after 24 weeks off therapy — is now the goal of treatment, but is rarely achieved with current therapy. Understanding ...

    Seng Gee Lim, Thomas F. Baumert in Nature Reviews Gastroenterology & Hepatolo… (2023)

  6. Article

    Open Access

    Implementation of a randomized mobile-technology lifestyle program in individuals with nonalcoholic fatty liver disease

    Identifying effective, feasible, low-cost interventions that promote sustainable lifestyle changes in nonalcoholic fatty liver disease (NAFLD) is a key unmet need. The aim of this study was to assess predictor...

    Monica A. Tincopa, Nik Patel, Areesha Shahab, Haila Asefa in Scientific Reports (2024)

Page of 2 next disabled